Integrated safety across six clinical trials of alpha-1 augmentation therapy
R. Sandhaus, K. R. Chapman, J. Burdon, E. Piitulainen, N. Seersholm, J. Stocks, J. Edelman, M. Bexon, L. Huang, N. G. McElvaney (Denver, Tyler, King of Prussia, United States Of America; Toronto, Canada; Melbourne, Australia; Malmo, Sweden; Hellerup, Denmark; Bern, Switzerland; Dublin, Ireland)
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Sandhaus, K. R. Chapman, J. Burdon, E. Piitulainen, N. Seersholm, J. Stocks, J. Edelman, M. Bexon, L. Huang, N. G. McElvaney (Denver, Tyler, King of Prussia, United States Of America; Toronto, Canada; Melbourne, Australia; Malmo, Sweden; Hellerup, Denmark; Bern, Switzerland; Dublin, Ireland). Integrated safety across six clinical trials of alpha-1 augmentation therapy. Eur Respir J 2014; 44: Suppl. 58, 950
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: